Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties
- PMID: 1650447
Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties
Abstract
Acute promyelocytic leukemia (APL) is characterized by the 15;17 chromosomal translocation. Cloning experiments have established that the chromosome 17 breakpoint maps to the RAR alpha and the 15 to the myl locus. The resulting chimeric gene is transcribed as a myl/RAR alpha fusion mRNA. By isolating both normal myl and APL myl/RAR alpha cDNAs, we showed that the myl/RAR alpha mRNA encodes for a putative fusion protein with a molecular weight of about 103 kDa, which is made up of 530 amino acids derived from the myl N-terminus and 402 amino acids originating from the RAR alpha C-terminus. The protein includes the RAR alpha DNA and retinoid-binding regions but lacks the A portion of the N-terminal region (A/B region) which is thought to contain one of the RAR alpha transactivation domains. The myl/RAR alpha protein acted as a retinoid-inducible transcription factor with both ligand-independent repressor and ligand-dependent activator functions in transactivation experiments of a retinoic acid-responsive gene. Myl/RAR alpha exerted this dual function three times more effectively than RAR alpha and had about 10-fold greater affinity for RA than RAR alpha. Comparison of myl/RAR alpha genomic and cDNA sequences from the same case demonstrated that both chromosome 15 and 17 breakpoints occurred within introns and the myl and RAR alpha sequences are spliced in the same polyadenylated RNA.
Similar articles
-
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.Nature. 1990 Oct 11;347(6293):558-61. doi: 10.1038/347558a0. Nature. 1990. PMID: 2170850
-
Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.Cancer Res. 1992 Jul 1;52(13):3687-92. Cancer Res. 1992. PMID: 1319828
-
Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.Oncogene. 1992 Jun;7(6):1223-32. Oncogene. 1992. PMID: 1375719
-
[Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].Bull Cancer. 1992;79(7):697-704. Bull Cancer. 1992. PMID: 1334741 Review. French.
-
[Retinoids and acute promyelocytic leukemia].Gan To Kagaku Ryoho. 1991 Oct;18(13):2203-9. Gan To Kagaku Ryoho. 1991. PMID: 1656889 Review. Japanese.
Cited by
-
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.J Cell Biol. 1999 Oct 18;147(2):221-34. doi: 10.1083/jcb.147.2.221. J Cell Biol. 1999. PMID: 10525530 Free PMC article.
-
The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18715-20. doi: 10.1073/pnas.0604800103. Epub 2006 Nov 22. Proc Natl Acad Sci U S A. 2006. PMID: 17121994 Free PMC article.
-
Epigenetic regulation by RARα maintains ligand-independent transcriptional activity.Nucleic Acids Res. 2012 Jan;40(1):102-15. doi: 10.1093/nar/gkr637. Epub 2011 Sep 12. Nucleic Acids Res. 2012. PMID: 21911359 Free PMC article.
-
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity.Adv Sci (Weinh). 2020 Feb 27;7(8):1902130. doi: 10.1002/advs.201902130. eCollection 2020 Apr. Adv Sci (Weinh). 2020. PMID: 32328411 Free PMC article.
-
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.EMBO J. 1993 Aug;12(8):3171-82. doi: 10.1002/j.1460-2075.1993.tb05986.x. EMBO J. 1993. PMID: 8393784 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources